Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Nico C. van Walree, MD"'
Autor:
Lysanne A. Lievense, MD, PhD, Peter Heukels, MD, PhD, Nico C. van Walree, MD, Cor H. van der Leest, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 1, Pp 100441- (2023)
Introduction: Immune checkpoint inhibition (ICI) is an important treatment modality in metastatic NSCLC and management of immunotherapy-related adverse effects (irAEs) can be challenging. Retreatment after discontinuation of ICI because of irAEs is a
Externí odkaz:
https://doaj.org/article/3dd65decf6dd4073a810a737dd461e0d
